1. Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations;Berntorp;Haemophilia,1996
2. Successful immunetolerance therapy of F VIII-inhibitor in children after changing from high to intermediate purity F VIII concentrate;Kreuz;Ann Hematol,1996
3. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction;Leissinger;Am J Hematol,2004
4. The role of immunomodulation in the management of factor VIII inhibitors;Lillicrap;Hematology Am Soc Hematol Educ Program,2006
5. Role of von Willebrand factor in immune tolerance induction;Escuriola Ettingshausen;Blood Coagul Fibrinolysis,2005